You are more unique than your fingerprint. The very cells that make you who you are tell your physician critical information about your health. We see your uniqueness with science, and custom-tailor your treatment to match you and only you.

You drive us to find treatments, comfort and cures. Our mission is to bring the revolutionary advances of 21st century care to you.

Learn More
For the first time, clinicians will now be able to measure the presence of protein biomarkers in the patient's tumor cells at an extremely low quantitative level at attomoles per microgram of tumor tissue. Protein biomarkers known to induce drug resistance or indicate drug sensitivity for chemotherapy, monoclonal antibody therapy, hormonal therapy, targeted therapy and immunotherapy can now be identified from patient's tumor tissue (Liquid Tissue™) by the GPS Cancer™ test. These findings will enable personalized cancer care for patients with actionable insights for:

  • Chemotherapy
  • Monoclonal antibody therapy
  • Hormonal therapy
  • Targeted therapy
  • Immunotherapy

Addressing the question:
“Doctor, what information do you have from my tumor tissue that will help inform you that the treatment you are about to prescribe has a probability of being effective?”